ÂÜẠ̀ẨÂ×

Mike Grippo was named Senior Vice President, Strategy & Corporate Development in October 2019. He joined Catalent in April 2016 as Catalent’s Vice President of Corporate Development where he was charged with executing value-driving deals and developing a disciplined, inorganic growth strategy for the company.

Prior to joining Catalent, Mike was co-leader of corporate development for medical device company CR Bard, and held similar roles of leadership with Hill-Rom Holdings, Inc., a publicly traded medical technology company, and Welch Allyn, Inc., a privately held medical products company. Mike also previously worked as an investment banker for 12 years, primarily with SG Cowen and UBS Securities and Dillon Read.